Johnson & Johnson
JNJ
$158.88
Share price
0.32%
Change (1 day)
-11.13%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Earnings for Johnson & Johnson (JNJ)
Earnings in 2023 (TTM): $24.43 B
According to Johnson & Johnson's latest financial reports the company's current earnings (TTM) are $24.43 B. In 2022 the company made an earning of $24.31 B an increase over its 2021 earnings that were of $21.75 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Johnson & Johnson from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $24.43 B | 0.51% |
| 2022 | $24.31 B | 11.78% |
| 2021 | $21.75 B | 9.22% |
| 2020 | $19.91 B | -5.04% |
| 2019 | $20.97 B | -0.97% |
| 2018 | $21.17 B | 10.74% |
| 2017 | $19.12 B | -9.65% |
| 2016 | $21.16 B | 15.73% |
| 2015 | $18.28 B | -13.47% |
| 2014 | $21.13 B | 11.5% |
| 2013 | $18.95 B | 19.05% |
| 2012 | $15.92 B | 16.59% |
| 2011 | $13.65 B | -11.6% |
| 2010 | $15.45 B | -3.21% |
| 2009 | $15.96 B | -8.07% |
| 2008 | $17.36 B | 14.14% |
| 2007 | $15.21 B | 10.97% |
| 2006 | $13.70 B | 2.53% |
| 2005 | $13.37 B | 3.94% |
| 2004 | $12.86 B | 18.33% |
| 2003 | $10.87 B | 12.33% |
| 2002 | $9.67 B | 23.19% |
| 2001 | $7.85 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $8.80 B | -63.98% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.25 B | -49.86% | 🇺🇸 USA |
 Abbott Laboratories ABT | $6.18 B | -74.67% | 🇺🇸 USA |
 Medtronic MDT | $6.11 B | -74.97% | 🇮🇪 Ireland |
 Eli Lilly LLY | $6.14 B | -74.87% | 🇺🇸 USA |
 Sanofi SNY | $10.77 B | -55.90% | 🇫🇷 France |
 Gilead Sciences GILD | $7.23 B | -70.39% | 🇺🇸 USA |
 Stryker Corporation SYK | $3.20 B | -86.87% | 🇺🇸 USA |
 Merck MRK | $8.15 B | -66.64% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $9.02 B | -63.08% | 🇬🇧 UK |